Delisted
No longer trades. Fund positions are valued at its last close, $84.95 on Aug 31, 2026. View SEC filing
CRINETICS PHARMACEUTICALS IN
CRNX·22663K107·US·Common Stock·Healthcare - Biotechnology-13D/G
CRNX (CRINETICS PHARMACEUTICALS IN) is held by 137 institutional investors as of Q2 2026. Largest holders: FMR LLC ($592.7M), BlackRock, Inc. ($365.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($336.4M).
137
Holders
(11 Elite)
$4B
Total Value
58%
Consensus
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 31, 2026 · Insiders Sep 1, 2026 · Activists Aug 13, 2026 · Congress none
InsiderKIKalofonos IsabelDisp $142KSep 1, 2026
InsiderNWNichols WestonDisp $1.4MSep 1, 2026
InsiderVRVivaldi Coelho RogerioDisp $1.1MSep 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 150
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer